Rubric Capital Management (New York)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-199,883
Closed -$680K 70
2018
Q3
$680K Buy
+199,883
New +$680K 0.07% 50